Patient Presents With Hematuria
A 46-year-old man presents with hematuria, and a bladder biopsy is performed. What is your diagnosis?
Advanced RCC Can Still Respond to Nivolumab After Initial Progression
A subset of patients with advanced renal cell carcinoma experienced a reduction in tumor size after undergoing postprogression treatment with nivolumab.
FDA Cracks Down on Unapproved Direct-to-Consumer Cancer ‘Cures’
The FDA has sent warning letters to 14 companies marketing dozens of unapproved “miracle cure” products online with fraudulent claims that they prevent or cure cancer.
Long Delay From Positive Fecal Test to Colonoscopy May Increase CRC Risk
A delay of 10 months or longer between a positive fecal immunochemical test and a follow-up colonoscopy was associated with a higher risk of colorectal cancer.
Maintenance Lenalidomide Delayed Progression After R-CHOP for DLBCL
Maintenance lenalidomide significantly prolonged progression-free survival in elderly patients with diffuse large B-cell lymphoma who responded to first-line R-CHOP.
Second Primary Malignancies More Deadly in Younger Cancer Patients
Younger cancer survivors experience worse survival outcomes following a second primary cancer diagnosis than their older counterparts, according to a recent study.
ASCO Updates Pancreatic Cancer Guideline to Include Doublet Chemotherapy
ASCO updated a 2016 guideline regarding resected pancreatic cancer to include treatment with adjuvant chemotherapy with gemcitabine and capecitabine.
Nivolumab Yields 12-Month Survival of Nearly 60% in Advanced HCC
Interim data from CheckMate 040 showed that nivolumab produces durable responses with promising long-term survival rates in patients with advanced, unresectable hepatocellular carcinoma.
Vaginal Bleeding in 32-Year-Old Patient
A 32-year-old woman presents with vaginal bleeding, and a cervical biopsy is obtained. What is your diagnosis?
Surgery Plus RT Improves Survival Over Chemo Plus RT in Oral Cavity Carcinoma
Surgery followed by postoperative radiotherapy was associated with prolonged overall survival compared with concurrent chemoradiotherapy in patients with locally advanced oral cavity squamous cell carcinoma.
By clicking Accept, you agree to become a member of the UBM Medica Community.